| Literature DB >> 33807679 |
Marta Gandolla1,2, Lorenzo Niero1, Franco Molteni3, Elenora Guanziroli3, Nick S Ward4,5, Alessandra Pedrocchi1,6.
Abstract
Functional Electrical Stimulation (FES) has demonstrated to improve walking ability and to induce the carryover effect, long-lasting persisting improvement. Functional magnetic resonance imaging has been used to investigate effective connectivity differences and longitudinal changes in a group of chronic stroke patients that attended a FES-based rehabilitation program for foot-drop correction, distinguishing between carryover effect responders and non-responders, and in comparison with a healthy control group. Bayesian hierarchical procedures were employed, involving nonlinear models at within-subject level-dynamic causal models-and linear models at between-subjects level. Selected regions of interest were primary sensorimotor cortices (M1, S1), supplementary motor area (SMA), and angular gyrus. Our results suggest the following: (i) The ability to correctly plan the movement and integrate proprioception information might be the features to update the motor control loop, towards the carryover effect, as indicated by the reduced sensitivity to proprioception input to S1 of FES non-responders; (ii) FES-related neural plasticity supports the active inference account for motor control, as indicated by the modulation of SMA and M1 connections to S1 area; (iii) SMA has a dual role of higher order motor processing unit responsible for complex movements, and a superintendence role in suppressing standard motor plans as external conditions changes.Entities:
Keywords: carryover effect; dynamic causal modeling (DCM); fMRI; functional electrical stimulation (FES); parametric empirical bayes (PEB)
Year: 2021 PMID: 33807679 PMCID: PMC8002039 DOI: 10.3390/brainsci11030329
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Representation of steps involved in the procedure for model structure identification. STEP 1: input matrix definition (i.e., C matrix) for controls group; STEP 2: structural matrix definition (i.e., A matrix) for controls group; STEP 3: bilinear matrix definition (i.e., B matrix) for controls group; STEP 4: input matrix definition (i.e., C matrix) for patients; STEP 5: structural matrix definition (i.e., A matrix) for patients’ group; STEP 6: bilinear matrix definition (i.e., B matrix) for patients’ group. M1: primary motor cortex; S1: primary somatosensory cortex; SMA: supplementary motor area; AG: angular gyrus; BMA: Bayesian model average.
Patients’ individual characteristics. R: right; L: left; MCA: middle cerebral artery; GP: globus pallidus; H: hemorrhagic; I: ischemic.
| Subject | Age | Site of Lesion | Type of Stroke | Time |
|---|---|---|---|---|
| 01 | 20–25 | R MCA | H | 23 |
| 02 | 35–40 | R GP | I | 23 |
| 03 | 60–65 | L MCA | H + I | 13 |
| 04 | 18–20 | L MCA | H | 44 |
| 05 | 45–50 | L GP | H | 44 |
| 06 | 20–25 | R MCA | I | 30 |
| 07 | 45–50 | R GP | I | 13 |
| 08 | 60–65 | R MCA | H | 58 |
Patients’ pre-post clinical scores and carry-over evaluation. TAAI: Tibialis Anterior Activation Index; MRC: Medical Research Council index.
| Subj. | Gait | Endurance Velocity | Paretic Step Length | TAAI | MRC | Capacity SCORE | Carry-Over |
|---|---|---|---|---|---|---|---|
| 01 | Yes | ||||||
| 02 | No | ||||||
| 03 | Yes | ||||||
| 04 | No | ||||||
| 05 | Yes | ||||||
| 06 | No | ||||||
| 07 | No | ||||||
| 08 | Yes |
Mean ROI coordinates of patients and controls ± standard deviation. M1: primary motor cortex; S1: primary somatosensory cortex; SMA: supplementary motor area; AG: angular gyrus.
| PATIENTS | CONTROLS | |||||
|---|---|---|---|---|---|---|
| x [mm] | y [mm] | z [mm] | x [mm] | y [mm] | z [mm] | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Figure 2The architecture of the outcome winning model from each methodological STEP. (A) STEP 1: winning input matrix (i.e., C matrix) for controls group; (B) STEP 4: input matrix for patients group defined as the winning model in STEP 1; (C) STEP 2: winning structural matrix (i.e., A matrix) for controls group; (D) STEP 5: winning structural matrix for patients group; (E) STEP 3: winning bilinear matrix (i.e., B matrix) for controls group; (F) STEP 6: winning bilinear matrix for patients group.
Figure 3Healthy controls and patients Dynamic Causal Modelling (DCM) estimates in matrix representation. V: voluntary input; P: proprioceptive input; M1: primary motor cortex; S1: primary sensorimotr cortex; SMA: supplementary motor area; AG: angular gyrus; m: mean component; CE: carryover effect regressor; t: time regressor; CS: capacity score regressor.
Figure 4Graphical representation of estimated values for patients and healthy controls. (A) input matrix (i.e., C matrix) on S1 area. (B) Dependence of the influence of V factor (i.e., C matrix) over SMA area on the capacity score value. Intrinsic and extrinsic estimated parameters (i.e., A matrix – blue bars, B matrix – red bars) for (C) M1 to SMA connection; (D) SMA to M1 connection; (E) M1 to S1 connection; (F) SMA to S1 connection; (G) S1 to M1 connection; (H) S1 to SMA connection. V: voluntary input; P: proprioceptive input; M1: primary motor cortex; S1: primary sensorimotor cortex; SMA: supplementary motor area; AG: angular gyrus; CE: carryover effect responders; nCE: carryover effect non-responders; HC: healthy controls; PZ: patients; “pre” represent to code for pre-training (or baseline) acquired images; “post” represents the code for post-training acquired images.